Pharmacy Buying Association, Inc.

Pharmacy Buying Association, Inc., doing business as PBA Health, a Kansas City, Missouri–based small business, is a prime contractor supplying pharmaceutical products, medical and surgical supplies, and related distribution services to the Department of Veterans Affairs as purchase orders and delivery orders under multiple indefinite delivery vehicles and Federal Supply Schedule contracts. The vendor competes predominantly under small business set-asides (Total Small Business designation recurs across the majority of recent awards), though a material share of higher-value awards—including several million-dollar single-item procurements—are full-and-open competitive.

PBA Health's footprint is almost exclusively concentrated within the VA healthcare system across multiple Veterans Integrated Service Networks (VISNs). The vendor has received 1,542 federal awards since 2006, all as prime contractor (100% prime split). Over the past five years, award volume has declined from 81 in 2022 to just five in 2026 year-to-date, a trajectory reflecting either portfolio contraction or maturation into fewer, larger orders. Recent representative work includes a $2.18 million unrestricted purchase order from VISN 15 for Duloxetine HCl capsules in three dosage strengths (February 2026); a $514,928 order from VISN 15 for Sumatriptan 6MG/0.5ML injectable syringes (April 2026); and a $23,378 Total Small Business set-aside from VISN 22 for Memantine HCl 10mg tablets (June 2026). The vendor also fulfills multi-line pharmaceutical and medical supply orders valued in the $30,000 to $200,000 range with delivery to Consolidated Mail Outpatient Pharmacies (CMOPs) across the VA's regional networks.

Customer concentration is extreme. Veterans Integrated Service Network 15 accounts for 694 awards (45% of total volume) and $108.3 million (64% of combined potential value); VISN 12 ranks second with 99 awards and $23.1 million. Together, the top five VISN customers cover 78% of award count and 93% of combined potential value. This concentration reflects PBA Health's established position as a pharmaceutical supplier to VA regional mail-order and outpatient pharmacy operations in the Kansas City and Midwest regions. The vendor holds a $382,200 single-award Indefinite Delivery Contract with VISN 15 (awarded January 2022, expiring December 2022) and places task orders under a $15.6 million multiple-award Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs. Additional parent vehicles include the VA NCO 15 Valproic Acid 2016-2021 IDC (68 task orders, $1.5 million) and three other IDIQ vehicles carrying between 19 and 53 task orders each.

PBA Health's product portfolio spans branded and generic pharmaceuticals across pain management, cardiology, endocrinology, ophthalmics, infectious disease, and psychiatric categories, as well as medical devices such as insulin pump reservoirs (OmniPod, T:Slim X2), diagnostic supplies, and over-the-counter items (eye drops, creams, topical solutions). Orders are typically firm-fixed-price, with 10-day delivery requirements to CMOPs nationwide. The vendor's registration as a federal contractor dates to 2007 and is characterized by compliance with Drug Supply Chain Security Act documentation, state wholesale distributor licensing, and Buy American Act certification where required.

The recompete and activity outlook presents material exposure: combined potential value of awards with ultimate completion dates in the next twenty-four months (as of the source date, mid-2026) is embedded in the declining 2025–2026 trend. The shift from 81 awards per year (2022) to 26 (2025) and 5 (2026 YTD) signals either consolidation into larger IDIQ vehicles or loss of share to competing pharmaceutical wholesalers and prime vendors. Concentration risk within a single customer (VISN 15 = 64% of dollars) and within a single product category (Pharmaceutical Preparation Manufacturing = 1,244 of 1,542 awards) leaves limited diversification across agencies or capability areas.

PBA Health is a distributor of pharmaceutical products and a provider of various services to retail pharmacies.